Welcome to LookChem.com Sign In|Join Free
  • or
Benzeneethanol, 3-fluoro-4-hydroxy-, also known as 3-fluoro-4-hydroxybenzeneethanol or 3-fluoro-4-hydroxyphenethyl alcohol, is an organic compound with the chemical formula C8H9FO2. It is a derivative of benzeneethanol, featuring a fluorine atom at the 3-position and a hydroxyl group at the 4-position on the benzene ring. Benzeneethanol, 3-fluoro-4-hydroxy- is a colorless to pale yellow liquid with a molecular weight of 156.15 g/mol. It is used in the synthesis of various pharmaceuticals, agrochemicals, and other specialty chemicals due to its unique structural properties. The presence of the fluorine atom imparts specific reactivity and lipophilicity to the molecule, making it a valuable building block in the development of new drugs and chemical compounds.

5497-21-2

Post Buying Request

5497-21-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5497-21-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5497-21-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,9 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 5497-21:
(6*5)+(5*4)+(4*9)+(3*7)+(2*2)+(1*1)=112
112 % 10 = 2
So 5497-21-2 is a valid CAS Registry Number.

5497-21-2Relevant academic research and scientific papers

Tricyclic dihydroimidazopyrimidinone derivative, and preparation method, pharmaceutical composition and application thereof

-

Paragraph 0822-0825, (2021/05/12)

The invention provides a compound as shown in a general formula (I), cis-trans isomers, enantiomers, diastereoisomers, racemes, solvates, hydrates or pharmaceutically acceptable salts or prodrugs of the compound, a preparation method of the compound, a pharmaceutical composition containing the compound and an application of the compound as aLp-PLA2 inhibitor, wherein R1, R2, Rx, Ra, Q, U, X, Y, m, n and A are defined in the specification.

BICYCLIC PYRIMIDONE COMPOUNDS

-

Paragraph 0522, (2014/07/08)

The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.

BICYCLIC PYRIMIDONE COMPOUNDS

-

Page/Page column 58; 59, (2013/03/26)

The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5497-21-2